SCHEMBL111371

SCHEMBL111371

CCCOC(=O)[C@@H](N)CS

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.44
SLC7A11 Q9UPY5 1/20 0.44
HCAR2 Q8TDS4 1/20 0.36
ALDH1A1 P00352 4/20 0.35
LMNA P02545 1/20 0.34
ESR1 P03372 1/20 0.33
CHRM1 P11229 1/20 0.33
TSHR P16473 1/20 0.33
SLC6A2 P23975 1/20 0.33
KDR P35968 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CPB2 Q96IY4 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111370 1.00 PTGS1 (0.44) PTGS1SLC7A11HCAR2ALDH1A1LMNA
SCHEMBL25186208 0.98 PTGS1 (0.43) PTGS1SLC7A11HCAR2ALDH1A1LMNA
SCHEMBL113393 0.88 ALDH1A1 (0.48) PTGS1SLC7A11HCAR2ALDH1A1LMNA
SCHEMBL113394 0.88 ALDH1A1 (0.48) PTGS1SLC7A11HCAR2ALDH1A1LMNA
SCHEMBL1063905 0.86 NAAA (0.47) PTGS1SLC7A11HCAR2ALDH1A1TSHR
Hydrochloric Acid SCHEMBL9588194 0.86 ALDH1A1 (0.47) PTGS1SLC7A11HCAR2ALDH1A1LMNA
SCHEMBL25179254 0.86 ALDH1A1 (0.47) PTGS1SLC7A11HCAR2ALDH1A1LMNA
SCHEMBL112307 0.84 NAAA (0.50) HCAR2ALDH1A1LMNATSHRNOD1
SCHEMBL25183414 0.84 NAAA (0.46) PTGS1SLC7A11HCAR2ALDH1A1TSHR
Hydrochloric Acid SCHEMBL9588157 0.84 NAAA (0.46) HCAR2ALDH1A1TSHRNOD1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110746225-A Nano controlled release fertilizer and preparation method thereof 中国热带农业科学院农产品加工研究所 2020-02-04 CN claimed
CN-109477840-A For non-destructively determining the method and system of Fowl Sex in ovum 因欧沃私人有限责任公司 2019-03-15 CN claimed
CN-102802605-A Stable lipid formulations of apoptosis promoters ABBOTT LAB 2012-11-28 CN claimed
EP-2424499-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER Abbott Laboratories (US) 2012-03-07 EP claimed
WO-2010127193-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER ABBOTT LABORATORIES (US) 2010-11-04 WO claimed
US-20100278905-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER ABBVIE INC. 2010-11-04 US claimed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
US-20040220264-A1 Bioavailability and improved delivery of acidic pharmaceutical drugs YU RUEY J 2004-11-04 US claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
EP-1379214-A1 HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING SAME L'OREAL, S.A. (FR) 2004-01-14 EP claimed
US-20020159962-A1 Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same L'OREAL S.A. (FR) 2002-10-31 US claimed
WO-2002067875-A1 HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING THE SAME L'OREAL S.A. (FR) 2002-09-06 WO claimed
CN-120040435-A Mangiferin and derivatives thereof, preparation method and medical application thereof 安徽中医药大学 2025-05-27 CN disclosed
CN-110746225-A Nano controlled release fertilizer and preparation method thereof 中国热带农业科学院农产品加工研究所 2020-02-04 CN disclosed
CN-109477840-A For non-destructively determining the method and system of Fowl Sex in ovum 因欧沃私人有限责任公司 2019-03-15 CN disclosed
US-9758688-B2 Composition for forming conductive film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
WO-1992004024-A2 TOXIC AGENT PROTECTIVE COMPOUNDS, COMPOSITIONS AND METHOD THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) 1992-03-19 WO disclosed
US-4992267-A Mixture of alkali metal hydroxide and disulfide reducing agent JOHNSON PRODUCTS CO., INC. (US) 1991-02-12 US disclosed
EP-0326799-A2 Enzymatic process for synthesizing peptides Degussa Aktiengesellschaft (DE) 1989-08-09 EP disclosed
US-3952115-A Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters THE PROCTER & GAMBLE COMPANY (US) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100278905-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER BCL2, BAX, BCOR PTGS1 783/4885SLC7A11 3219/4885HCAR2 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.